Home
Login Register
Clearbridge    Last:0.001    -0.001

SARS RELATED PLAYS..

 Post Reply 661-680 of 1587
 
dimebag
    24-Feb-2020 15:51  
Contact    Quote!
Many scooped up at 147
 
 
TeoMark
    24-Feb-2020 15:45  
Contact    Quote!
Possible next wave of short coming. 4:30pm.
 
 
trademaster
    24-Feb-2020 15:34  
Contact    Quote!
Mkt always ahead and now pricing in worst viral scenario...and negative dow futures

guards80      ( Date: 24-Feb-2020 15:04) Posted:

Korea keep rise. Now 801cases 7death

Sgvale      ( Date: 24-Feb-2020 15:02) Posted:

This one also tio virus already


 

 
dimebag
    24-Feb-2020 15:27  
Contact    Quote!
Wah this one chui diao big time
 
 
T-Gunner
    24-Feb-2020 15:27  
Contact    Quote!
just free falling now
 
 
guards80
    24-Feb-2020 15:04  
Contact    Quote!
Korea keep rise. Now 801cases 7death

Sgvale      ( Date: 24-Feb-2020 15:02) Posted:

This one also tio virus already

 

 
Sgvale
    24-Feb-2020 15:02  
Contact    Quote!
This one also tio virus already
 
 
benny100
    24-Feb-2020 14:04  
Contact    Quote!
FY result will either release on friday or Saturday.
 
 
Hellvish
    24-Feb-2020 12:51  
Contact    Quote!
Agree with you! Slow and steady 
 
 
fenizz
    24-Feb-2020 12:46  
Contact    Quote!
Shortist waiting to short any counter that spike up. Best way is to go up bit by bit daily so they have no room to short.

guards80      ( Date: 24-Feb-2020 10:54) Posted:

all medical stock not much power also... not sure why.

 

 
dimebag
    24-Feb-2020 11:38  
Contact    Quote!
My guess is because the situation in Asia (except S. Korea) is stabilising

guards80      ( Date: 24-Feb-2020 10:54) Posted:

all medical stock not much power also... not sure why.

 
 
Justice888
    24-Feb-2020 11:30  
Contact    Quote!
Bec still accumulation mode?

guards80      ( Date: 24-Feb-2020 10:54) Posted:

all medical stock not much power also... not sure why.

 
 
guards80
    24-Feb-2020 10:54  
Contact    Quote!
all medical stock not much power also... not sure why.
 
 
benny100
    24-Feb-2020 09:48  
Contact    Quote!
The management did alot of shares buyback on may/june 2018.
 
 
Integrity
    24-Feb-2020 07:32  
Contact    Quote!
Chiong ahh!!
 

 
Sgvale
    24-Feb-2020 05:35  
Contact    Quote!
China has changed the calculation of confirmed cases but outside China confirmed cases & death are worsening. From Korea to Italy to Iran. Very worrisome
 
 
Power1
    22-Feb-2020 15:07  
Contact    Quote!
Just a matter of time it will fly🚀

Sgvale      ( Date: 22-Feb-2020 14:35) Posted:

SINGAPORE (Feb 5): Emerging areas of precision medicine could transform loss-making healthcare group Clearbridge Health into a ?potential unicorn in the making?, according to Tayrona Financial, the independent equity research house formerly known as NRA Capital.

?We see high growth potential for the company as doctors increasingly customise treatments to patients? genetic composition,? says analyst Liu Jinshu in a Jan 31 report. ?With its network across Asia, Clearbridge is positioning itself to tap on this trend over the next five to ten years.?

?With a stream of profitable acquisitions, we expect Clearbridge to turn EBITDA positive in 2020 and report its maiden profit in 2021,? Liu says. He notes that the company?s management has a track record of running and monetising medical technology businesses.

?We believe that Clearbridge deserves an aggressive valuation for its high future growth potential. Hence, we value Clearbridge at US$201.3 million,? Liu says. This translates to a fair value estimate of 41 cents .

 
 
Sgvale
    22-Feb-2020 14:35  
Contact    Quote!
SINGAPORE (Feb 5): Emerging areas of precision medicine could transform loss-making healthcare group Clearbridge Health into a ?potential unicorn in the making?, according to Tayrona Financial, the independent equity research house formerly known as NRA Capital.

?We see high growth potential for the company as doctors increasingly customise treatments to patients? genetic composition,? says analyst Liu Jinshu in a Jan 31 report. ?With its network across Asia, Clearbridge is positioning itself to tap on this trend over the next five to ten years.?

?With a stream of profitable acquisitions, we expect Clearbridge to turn EBITDA positive in 2020 and report its maiden profit in 2021,? Liu says. He notes that the company?s management has a track record of running and monetising medical technology businesses.

?We believe that Clearbridge deserves an aggressive valuation for its high future growth potential. Hence, we value Clearbridge at US$201.3 million,? Liu says. This translates to a fair value estimate of 41 cents .
 
 
Battle123
    21-Feb-2020 21:33  
Contact    Quote!
I think they don like to wear mask, may damage their delicate skin !
 
 
Sgvale
    21-Feb-2020 20:14  
Contact    Quote!
What's wrong with South Korea. Sudden 200+ cases? Mini Wuhan ? Scary
 
Important: Please read our Terms and Conditions and Privacy Policy .